Authors

Andrew M. Wood, MD
Recent : iRARC adoption is slow but persistent in bladder cancer

Wood is a urologic oncology fellow at Glickman Urological & Kidney Institute at the Cleveland Clinic in Ohio.

Andrew Radtke, MD
Recent : Going “retro”: A perspective on robotic retroperitoneal renal surgery
Stephen A. Boorjian, MD
Recent : Strategies to mitigate impact of intravenous ICM shortage
Caroline Seymour
Recent : Testicular cancer patient has complete response to CAR T-cell therapy
Janelle Hart
Recent : Asked by a Resident: Dr. Efe Chantal Ghanney Simons interviews Dr. Mark S. Litwin
Dr. Kristen Scarpato, MD, MPH
Brian Helfand, MD, PhD
Recent : Coming Soon: Clinical Review of the Management of Two Men With Prostate Cancer
Kathleen M. Olson, MD
Recent : Urologic implications of Lynch syndrome
Rachelle Manookian, MS, CGC
Recent : What is genetic discrimination, and why does it matter?

Rachelle Manookian, MS, LCGC, is a board-certified genetic counselor specializing in cancer genetics. She has an MS in genetic counseling from the Icahn School of Medicine at Mount Sinai, and a BS in biological sciences with a focus in neurobiology from University of California Irvine, as well as minors in Spanish literature and cognitive psychology.

Osman R. Minkara
Recent : Is now a good time to sell your medical practice to a private equity group?